F-group (family)
2003.1.1.9 AdoHcyase_NAD
Ligands and drugs
746
Member domains
440
with ligand contacts (≤ 4 Å)
59.0% of members
289
with DrugDomain annotations
38.7% of members
289
with a DrugBank compound
38.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.1.9 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 269 |
| DB00640 | ADN | Adenosine | 132 |
| DB00173 | ADE | Adenine | 18 |
| DB00157 | NAI | NADH | 14 |
| DB03769 | DEA | D-Eritadenine | 13 |
| DB04335 | NOS | Inosine | 10 |
| DB01752 | SAH | S-adenosyl-L-homocysteine | 8 |
| DB03273 | ADY | 3'-Oxo-Adenosine | 5 |
| DB12156 | 3AD | Cordycepin | 5 |
| DB04441 | 2FA | 2-Fluoroadenosine | 4 |
| DB04546 | AD3 | 3-Deazaadenosine | 4 |
| DB07052 | 3DH | 5'-S-ethyl-5'-thioadenosine | 4 |
| DB00194 | RAB | Vidarabine | 2 |
| DB00811 | RBV | Ribavirin | 2 |
| DB03216 | ADC | (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine | 2 |
| DB02774 | PDO | 1,3-Propanediol | 1 |
| DB09130 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 420 |
| Kmetal | POTASSIUM ION | 177 |
| ADE | ADENINE | 139 |
| ADN | ADENOSINE | 139 |
| NAmetal | SODIUM ION | 39 |
| CL | CHLORIDE ION | 22 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 14 |
| NOS | INOSINE | 14 |
| ZNmetal | ZINC ION | 14 |
| DEA | D-ERITADENINE | 12 |
| RBmetal | RUBIDIUM ION | 10 |
| 3DD | (2R,3R)-4-(4-AMINO-1H-IMIDAZO[4,5-C]PYRIDIN-1-YL)-2,3-DIHYDROXYBUTANOIC ACID | 8 |
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 8 |
| 9W4 | 4-[(2,5-dioxo-2,5-dihydro-1H-imidazol-1-yl)methyl]-N-[2-(morpholin-4-yl)-1,3-benzothiazol-6-yl]benzamide | 6 |
| ARJ | (2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-2-hydroxy-5-(hydroxymethyl)cyclopentanone | 6 |
| 3AD | 3'-DEOXYADENOSINE | 5 |
| 2FA | 2-(6-AMINO-2-FLUORO-PURIN-9-YL)-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3,4-DIOL | 4 |
| 3DH | 5'-S-ethyl-5'-thioadenosine | 4 |
| 6OS | Neplanocin-A | 4 |
| 7CY | (1R,2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol | 4 |